0000908662-16-000402.txt : 20160119 0000908662-16-000402.hdr.sgml : 20160118 20160119161946 ACCESSION NUMBER: 0000908662-16-000402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160114 FILED AS OF DATE: 20160119 DATE AS OF CHANGE: 20160119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY MARY ANN CENTRAL INDEX KEY: 0001261974 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 161348532 MAIL ADDRESS: STREET 1: 201 W 70TH ST, SUITE 23K CITY: NEW YORK STATE: NY ZIP: 10023 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-01-14 0000907562 DYAX CORP DYAX 0001261974 GRAY MARY ANN C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 1 0 0 0 Common Stock 2016-01-14 4 M 0 6000 2.97 A 16000 D Common Stock 2016-01-14 4 M 0 75000 3.82 A 91000 D Common Stock 2016-01-14 4 M 0 75000 2.09 A 166000 D Common Stock 2016-01-14 4 M 0 8107 2.06 A 174107 D Common Stock 2016-01-14 4 M 0 25000 6.17 A 199107 D Common Stock 2016-01-14 4 M 0 33333 26.23 A 232440 D Stock Option (right to buy) 2.97 2016-01-14 4 M 0 6000 0 D 2016-05-18 Common Stock 6000 0 D Stock Option (right to buy) 3.82 2016-01-14 4 M 0 75000 0 D 2018-05-15 Common Stock 75000 0 D Stock Option (right to buy) 2.09 2016-01-14 4 M 0 75000 0 D 2021-05-12 Common Stock 75000 0 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 8107 0 D 2017-06-20 Common Stock 8107 0 D Stock Option (right to buy) 6.17 2016-01-14 4 M 0 25000 0 D 2024-05-08 Common Stock 25000 0 D Stock Option (right to buy) 26.23 2016-01-14 4 M 0 33333 0 D 2025-05-12 Common Stock 33333 16667 D The options became fully exercisable on May 15, 2008. The options became fully exercisable on May 12, 2011. The options became fully exercisable on May 8, 2014. The options become exercisable in twelve (12) substantially equal installments on each monthly anniversary of the date of grant, May 12, 2015. /s/ Stacie S. Aarestad, as attorney-in-fact 2016-01-19